Esketamine induces embryonic and cardiac malformation through regulating the nkx2.5 and gata4 in zebrafish
Abstract Esketamine (EK) has been widely used in the treatment of depression, but the effects of EK prenatal treatment on embryonic heart development have been rarely reported. This study assesses the effects of varying concentrations of EK on embryonic development and cardiogenesis to determine the...
Prif Awduron: | Shuang Li, Xiang Li, Rui Zhao, Tingyu Jiang, Qiuyun Ou, Huansen Huang, Jiancheng Tang |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Nature Portfolio
2025-02-01
|
Cyfres: | Scientific Reports |
Mynediad Ar-lein: | https://doi.org/10.1038/s41598-025-91315-2 |
Eitemau Tebyg
-
Activation of the Nkx2.5–Calr–p53 signaling pathway by hyperglycemia induces cardiac remodeling and dysfunction in adult zebrafish
gan: Yanyi Sun, et al.
Cyhoeddwyd: (2017-10-01) -
GATA factors lie upstream of Nkx 2.5 in the transcriptional regulatory cascade that effects cardiogenesis.
gan: Brewer, A, et al.
Cyhoeddwyd: (2005) -
The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs.
gan: Jenny Schlesinger, et al.
Cyhoeddwyd: (2011-02-01) -
nkx2.7 transcription factor is involved in zebrafish cardiac development
gan: Simoes, A, et al.
Cyhoeddwyd: (2007) -
Esketamine Exposure Impairs Cardiac Development and Function in Zebrafish Larvae
gan: Shuo Huang, et al.
Cyhoeddwyd: (2024-06-01)